Medicine and Dentistry
Immunoglobulin
100%
Oncology
100%
Combination Therapy
77%
Patient
66%
Evaluation Study
44%
Adverse Event
33%
Development
22%
Toxicity
22%
Solid Malignant Neoplasm
22%
Assessment
22%
Accuracy
22%
Exercise
11%
Immunotherapy
11%
Outcome Assessment
11%
Chemotherapeutic Agent
11%
Drug
11%
Health Care Cost
11%
Therapeutic Procedure
11%
Weakness
11%
INIS
quality of life
88%
patients
77%
therapy
77%
evaluation
44%
assessments
44%
tools
33%
data
22%
solids
22%
tumors
22%
risks
22%
precision
22%
toxicity
22%
reliability
22%
drugs
11%
cost
11%
detection
11%
reviews
11%
values
11%
immunotherapy
11%
Nursing and Health Professions
Immunoglobulin
100%
Quality of Life
88%
Combination Therapy
77%
Patient-Reported Outcome
44%
Evaluation Study
44%
Adverse Event
33%
Reliability
22%
Toxicity
22%
Solid Malignant Neoplasm
22%
Quality of Life Assessment
22%
Electric Potential
22%
Outcome Assessment
11%
Drug
11%
Immunotherapy
11%
Strength
11%
Weakness
11%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin
100%
Adverse Event
33%
Toxicity
22%
Solid Malignant Neoplasm
22%
Tolerability
11%
Immunotherapy
11%
Drug
11%
Weakness
11%